AIDS
metrics 2024
Illuminating the Path to Effective Treatments
Introduction
AIDS, published by Lippincott Williams & Wilkins, stands as a premier journal within the fields of immunology and infectious diseases, reflecting a distinguished history since its inception in 1987 and offering insights that shape contemporary research and practice. With an impressive impact factor and categorized in the Q1 quartile across critical areas including Immunology, Infectious Diseases, and Immunology and Allergy, the journal showcases high-quality, peer-reviewed articles that consistently contribute to the advancement of knowledge and innovation in the fight against AIDS and related conditions. Researchers and professionals will find its content invaluable, as it brings forth groundbreaking studies, novel therapeutic approaches, and comprehensive reviews that inform both clinical practices and public health policies. Although not an open access journal, it remains a vital resource for those committed to addressing one of the most pressing global health challenges of our time.
Metrics 2024
Metrics History
Rank 2024
Scopus
IF (Web Of Science)
JCI (Web Of Science)
Quartile History
Similar Journals
AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV
Illuminating the Complexities of AIDS/HIV CareAIDS CARE - Psychological and Socio-Medical Aspects of AIDS/HIV, published by Routledge Journals, Taylor & Francis Ltd, serves as a vital interdisciplinary platform for researchers, clinicians, and policymakers exploring the complex psychological and socio-medical dimensions of HIV/AIDS. With an ISSN of 0954-0121 and an E-ISSN of 1360-0451, this esteemed journal has been disseminating significant research since 1989 and continues to uphold a commendable reputation in the field, achieving a Q2 ranking in esteemed categories such as Health (Social Science), Public Health, and Social Psychology as per 2023 metrics. Its commitment to enhancing understanding of HIV/AIDS through quantitative and qualitative research makes it essential for stakeholders engaged in health strategies and mental health interventions. While currently not offering open access, the journal provides access to a wealth of authoritative articles that contribute meaningfully to the ongoing discourse surrounding HIV/AIDS and its socio-psychological ramifications. Researchers and students aiming to deepen their knowledge and intervention strategies will find this journal an invaluable resource.
RHEUMATOLOGY INTERNATIONAL
Pioneering breakthroughs in therapeutic interventions.Rheumatology International, published by Springer Heidelberg, is a prestigious journal that focuses on innovative research in the field of rheumatology and immunology. Established in 1981, this peer-reviewed journal has contributed significantly to advancing our understanding of autoimmune disorders, clinical approaches, and therapeutic interventions. It holds a commendable Q2 ranking in the categories of Immunology, Immunology and Allergy, and Rheumatology as of 2023, showcasing its influence and importance within these disciplines. With a robust Scopus ranking—positioned 14 out of 73 in Medicine Rheumatology—it caters to a diverse audience of researchers, clinicians, and students committed to improving patient care and treatment modalities. Although it does not currently offer open access options, the journal remains a vital resource for insights on contemporary challenges and breakthroughs in rheumatological research, published from its base in Heidelberg, Germany.
Dermatologica Sinica
Unlocking New Insights in Dermatological ScienceDermatologica Sinica, published by Wolters Kluwer Medknow Publications, is an esteemed open-access journal in the field of dermatology that has been disseminating critical research since its inception in 2005. With an E-ISSN of 2223-330X and an ISSN of 1027-8117, this journal presents a platform for researchers, clinicians, and students to share cutting-edge findings and advancements in dermatological science. As of 2023, it proudly ranks in the Q2 category of dermatology journals and holds a notable position at rank #62 out of 142 in the Scopus Medicine - Dermatology category, placing it in the 56th percentile for impact. The journal transitioned to an open-access model in 2016, enhancing accessibility and visibility for groundbreaking studies worldwide. With a commitment to fostering innovation in the dermatological community, Dermatologica Sinica aims to advance the understanding and treatment of skin diseases while encouraging scholarly dialogue among practitioners and researchers across the globe.
AIDS Research and Treatment
Driving discovery in AIDS treatment.AIDS Research and Treatment is a premier open access journal published by HINDAWI LTD, dedicated to advancing the understanding and treatment of HIV/AIDS and related conditions. Launched in 2010, the journal has established itself as a vital resource for researchers, healthcare professionals, and students in the fields of Dermatology, Immunology, Infectious Diseases, and Public Health. With a notable 2023 impact factor reflected in its Q2 and Q3 quartile rankings across key medical categories, the journal plays a critical role in disseminating high-quality research and fostering innovation in the prevention and treatment of AIDS. It provides a wide range of open access options, enabling easier dissemination and increased visibility of research findings globally. As the landscape of HIV/AIDS research continues to evolve, AIDS Research and Treatment remains at the forefront, ensuring crucial insights and developments are shared to enhance public health outcomes.
AJAR-African Journal of AIDS Research
Elevating African Perspectives in AIDS ResearchAJAR - African Journal of AIDS Research, an esteemed publication by Taylor & Francis Ltd, stands at the forefront of research in the field of HIV/AIDS, with a specific focus on the African continent. Established in 2003 and publishing continuously through 2024, this journal serves as a crucial platform for disseminating innovative research findings aimed at addressing the challenges of HIV/AIDS. With its ISSN 1608-5906 and E-ISSN 1727-9445, AJAR is indexed in prominent databases and holds a respectable Q3 rating in major categories such as Infectious Diseases, Medicine, Public Health, and Virology as of 2023. This positions the journal as a relevant resource for scholars and medical professionals looking to stay informed on the latest developments and strategies in AIDS research. Although it is not currently an open-access journal, AJAR provides readers with valuable insights that are essential for advancing public health initiatives and infectious disease research across Africa and beyond. The journal's commitment to high-quality peer-reviewed research underscores its importance within its field, making it a vital resource for researchers, students, and policymakers alike.
Lancet HIV
Innovating solutions for a world affected by HIV.The Lancet HIV, published by Elsevier Inc in the United Kingdom, stands at the forefront of HIV research and public health, providing a vital platform for the dissemination of innovative findings and critical knowledge in the fields of epidemiology, immunology, infectious diseases, and virology. With its prestigious Q1 rankings in the aforementioned categories for 2023, the journal is recognized for its significant contribution to advancing understanding and addressing challenges posed by HIV globally. Its impressive standing, including a Scopus ranking in the 94th percentile for multiple categories, underscores its impact within the research community. The Lancet HIV publishes rigorously peer-reviewed research articles, reviews, and opinion pieces, ensuring that all stakeholders—researchers, practitioners, and policymakers—are engaged with up-to-date, evidence-based perspectives. Researchers and students alike will find this journal an invaluable resource for enhancing their knowledge and contributing to the ongoing discourse surrounding HIV treatment and prevention.
TROPICAL MEDICINE & INTERNATIONAL HEALTH
Transforming research into impactful health solutions.Tropical Medicine & International Health is a distinguished journal published by Wiley, dedicated to the exploration and dissemination of cutting-edge research in the fields of infectious diseases, parasitology, and public health. With a robust open-access option, the journal facilitates the widespread sharing of information critical to addressing health issues in tropical and international settings. Since its inception in 1996, it has established a significant presence in the academic community, as indicated by its impressive ranking in various Scopus categories, notably positioned in the Q1 quartile for Parasitology and Q2 for both Infectious Diseases and Public Health, reflecting its high influence within these domains. The journal's commitment to advancing knowledge on health challenges prevalent in tropical environments makes it an invaluable resource for researchers, healthcare professionals, and students alike who are dedicated to improving global health outcomes.
Frontiers in Pediatrics
Empowering the future of children's health with open access knowledge.Frontiers in Pediatrics is a distinguished open-access journal published by FRONTIERS MEDIA SA, dedicated to advancing the understanding and care of children's health across diverse medical disciplines. With its ISSN 2296-2360 and a commitment to disseminating high-quality research since its inception in 2013, the journal has rapidly established itself in the academic landscape, achieving a remarkable Q2 ranking in the Pediatrics, Perinatology, and Child Health category as of 2023. Based in Lausanne, Switzerland, and operating under a model that allows unrestricted access to its content, Frontiers in Pediatrics aims to facilitate knowledge sharing among researchers, clinicians, and policymakers. The journal's focus spans from clinical studies to public health initiatives, striving to address critical issues affecting pediatric populations globally. With a growing reputation, evidenced by its continuous presence in high-ranking databases, the journal promises to be a vital resource for those committed to improving pediatric health outcomes.
AIDS Research and Therapy
Empowering clinicians with cutting-edge findings.AIDS Research and Therapy is a prestigious peer-reviewed journal dedicated to disseminating cutting-edge research in the fields of AIDS and HIV therapy. Published by BMC, this Open Access journal has been freely available since its inception in 2004, facilitating global access to vital research findings. Based in the United Kingdom, the journal covers a diverse range of topics including molecular medicine, pharmacology, and virology, making it a crucial resource for researchers and clinicians alike. Recognized for its strong impact within the scientific community, it holds a Q2 quartile ranking in multiple categories as of 2023, including Molecular Medicine and Pharmacology. With an aim to enhance understanding and improve clinical outcomes for those affected by HIV/AIDS, AIDS Research and Therapy serves as an essential platform for the exchange of innovative ideas and practices that can inform future therapies and interventions. Researchers, professionals, and students seeking high-quality, peer-reviewed content will find this journal invaluable in advancing their knowledge and efforts in combating the HIV/AIDS epidemic.
INTERNATIONAL JOURNAL OF STD & AIDS
Innovative insights for a healthier tomorrow.INTERNATIONAL JOURNAL OF STD & AIDS is a prominent publication dedicated to advancing the understanding and treatment of sexually transmitted diseases and HIV/AIDS. Published by SAGE Publications Ltd, this esteemed journal has been contributing to the medical community since 1990, with a convergence of studies spanning to 2024. With its ISSN 0956-4624 and E-ISSN 1758-1052, the journal is recognized for its rigorous peer-reviewed research and has successfully positioned itself in the second quartile (Q2) of Dermatology and Public Health, alongside notable rankings in Infectious Diseases and Pharmacology. Currently based in the United Kingdom, this journal serves as a crucial resource for researchers, healthcare professionals, and students, providing a platform for innovative studies and critical reviews that address global health challenges. Although it does not offer Open Access, the journal continues to maintain its reputation as a vital reference point for those invested in the fields of dermatology, public health, and infectious diseases.